NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Ectodermal Dysplasia


Return to Library

Free Ectodermal Dysplasia Articles


Data from S. Rahighi et al provide new insights into cell biology



2009 MAY 26 - (NewsRx.com) -- According to a study from Tsukuba, Japan, "Activation of nuclear factor-kappa B (NF-kappa B), a key mediator of inducible transcription in immunity, requires binding of NF-kappa B essential modulator (NEMO) to ubiquitinated substrates. Here, we report that the UBAN (ubiquitin binding in ABIN and NEMO) motif of NEMO selectively binds linear (head-to-tail) ubiquitin chains."

"Crystal structures of the UBAN motif revealed a parallel coiled-coil dimer that formed a heterotetrameric complex with two linear diubiquitin molecules. The UBAN dimer contacted all four ubiquitin moieties, and the integrity of each binding site was required for efficient NF-kappa B activation. Binding occurred via a surface on the proximal ubiquitin moiety and the canonical Ile44 surface on the distal one, thereby providing specificity for linear chain recognition," wrote S. Rahighi and colleagues.

The researchers concluded: "Residues of NEMO involved in binding linear ubiquitin chains are required for NF-kappa B activation by TNF-alpha and other agonists, providing an explanation for the detrimental effect of NEMO mutations in patients suffering from X-linked ectodermal dysplasia and immunodeficiency."

Rahighi and colleagues published the results of their research in Cell (Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-kappa B Activation. Cell, 2009;136(6):1098-1109).

For additional information, contact S. Wakatsuki, High Energy Accelerator Research Organization KEK, Structural Biology Research Center, Photon Factory, Institute Materials Structural Science, Tsukuba, Ibaraki 3050801, Japan.

The publisher of the journal Cell can be contacted at: Cell Press, 600 Technology Square, 5TH Floor, Cambridge, MA 02139, USA.

Keywords: Japan, Tsukuba, Life Sciences, Cell Biology.

This article was prepared by Science Letter editors from staff and other reports. Copyright 2009, Science Letter via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login